Google-backed AI drug discovery startup Isomorphic Labs delays clinical trial timeline

Isomorphic Labs, which uses artificial intelligence for drug discovery, expects to have its first clinical trials by the end of 2026, founder and CEO Demis Hassabis said on Tuesday. ...